Anixa Biosciences, Inc. (ANIX) DCF Valuation

Anixa Biosciences, Inc. (Anix) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Anixa Biosciences, Inc. (ANIX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Anixa Biosciences, Inc. (ANIX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Explore el potencial financiero de Anixa Biosciences, Inc. (ANIX) con nuestra calculadora DCF fácil de usar! Ingrese sus proyecciones para el crecimiento, los márgenes y los gastos para calcular el valor intrínseco de Anixa Biosciences, Inc. (ANIX) y mejorar su enfoque de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .3 .0 .5 2,469.0 .2 .2 .1 .1 .1 .0
Revenue Growth, % 0 -100 0 481656.1 -99.99 -25 -25 -25 -25 -25
EBITDA -11.0 -10.0 -13.1 -13.7 -11.0 -.1 .0 .0 .0 .0
EBITDA, % -4401.98 100 -2552.44 -0.55606 -5221.43 -40.11 -40.11 -40.11 -40.11 -40.11
Depreciation .5 .1 .1 .0 .0 .1 .1 .0 .0 .0
Depreciation, % 186.52 100 11.68 0.00170109 21.9 46.72 46.72 46.72 46.72 46.72
EBIT -11.5 -10.1 -13.1 -13.8 -11.0 -.1 .0 .0 .0 .0
EBIT, % -4588.5 100 -2564.12 -0.55776 -5243.33 -40.11 -40.11 -40.11 -40.11 -40.11
Total Cash 5.8 9.1 35.7 29.7 23.8 .1 .1 .1 .1 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .0 .0 .0 .3
Account Receivables, % 26.61 100 0 0 128.57
Inventories -2.4 -2.6 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % -940 100 0 -0.0018631 0 -0.000372620494 -0.000372620494 -0.000372620494 -0.000372620494 -0.000372620494
Accounts Payable .6 .2 .1 .3 .2 .1 .1 .1 .0 .0
Accounts Payable, % 234.33 100 26.54 0.01073309 98.1 64.93 64.93 64.93 64.93 64.93
Capital Expenditure -.2 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -70.18 100 0 0 0 -14.04 -14.04 -14.04 -14.04 -14.04
Tax Rate, % 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2
EBITAT -11.6 -10.1 -13.0 -13.5 -10.9 -.1 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -8.5 -10.1 -15.6 -13.3 -11.2 .1 .0 .0 .0 .0
WACC, % 8.45 8.45 8.45 8.45 8.45 8.45 8.45 8.45 8.45 8.45
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -1
Equity Value 1
Diluted Shares Outstanding, MM 31
Equity Value Per Share 0.02

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore different scenarios.
  • Real-World Data: Anixa Biosciences, Inc. (ANIX) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template automatically calculates Net Present Value (NPV) and intrinsic value for your convenience.
  • Customizable and Professional: A refined Excel model designed to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive Data: Anixa Biosciences’ historical financial statements and pre-filled projections.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: View Anixa’s intrinsic value recalculating live.
  • Intuitive Visual Outputs: Dashboard graphs showcase valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-configured Excel file featuring Anixa Biosciences, Inc.'s (ANIX) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation insights to inform your investment strategy.

Why Choose This Calculator for Anixa Biosciences (ANIX)?

  • Accurate Data: Utilize real Anixa financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Ready-made calculations save you from starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.

Who Should Use This Product?

  • Investors: Evaluate Anixa Biosciences' valuation before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Gain insights into how biotech companies like Anixa Biosciences are appraised.
  • Consultants: Provide expert valuation analyses and reports for clients in the biotech sector.
  • Students and Educators: Utilize real data to learn and teach valuation strategies in biotechnology.

What the Template Contains

  • Pre-Filled Data: Features Anixa Biosciences' historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
  • Key Financial Ratios: Assess Anixa's profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.

No products were found matching.